Institution profile

社会医療法人黎明会 和歌山 健診クリニック・キタデ

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 01E2509005 +3

Location

Prefecture
Wakayama
Address
和歌山市七番丁26-1 モンティグレ ダイワロイネットホテル和歌山 2F

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • JSCSF再生医療等委員会
  • 安全未来特定認定再生医療等委員会

Public score

60.0/ 100

A · Review level
25.0 / 30
B · Technologies
18.5 / 35
C · Coverage
10.7 / 25
D · Class I / II technologies
5.8 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 60.0
Public score →100

Registered technologies (4)

Stem cells (all sources) 2
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来間葉系幹細胞を用いた変形性関節症治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
自己脂肪由来間葉系幹細胞を用いた靭帯・腱損傷治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
Adipose-derived stem cells 2
Registered technologies · Japanese originalTechnology areasPlan classification
自己脂肪由来間葉系幹細胞を用いた変形性関節症治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
自己脂肪由来間葉系幹細胞を用いた靭帯・腱損傷治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
PRP and platelet-derived 2
Registered technologies · Japanese originalTechnology areasPlan classification
自家多血小板血漿(Platelet-Rich Plasma:PRP)を用いた慢性関節炎の治療(関節内組織)PRP and platelet-derivedJoints and musculoskeletalClass II
自家多血小板血漿(Platelet-Rich Plasma:PRP)を用いた筋肉、腱、靭帯、筋膜の損傷及び慢性炎症の治療(関節外の軟部組織)PRP and platelet-derivedJoints and musculoskeletalClass III
Joints and musculoskeletal 4
Registered technologies · Japanese originalTechnology areasPlan classification
自家多血小板血漿(Platelet-Rich Plasma:PRP)を用いた慢性関節炎の治療(関節内組織)PRP and platelet-derivedJoints and musculoskeletalClass II
自己脂肪由来間葉系幹細胞を用いた変形性関節症治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
自己脂肪由来間葉系幹細胞を用いた靭帯・腱損傷治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
自家多血小板血漿(Platelet-Rich Plasma:PRP)を用いた筋肉、腱、靭帯、筋膜の損傷及び慢性炎症の治療(関節外の軟部組織)PRP and platelet-derivedJoints and musculoskeletalClass III

Certified committee for regenerative medicine

  • JSCSF再生医療等委員会
  • 安全未来特定認定再生医療等委員会

Public document number

  • 01E2509005
  • 01E2509006
  • 01E2511014
  • 01E2511020
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
自家多血小板血漿(Platelet-Rich Plasma:PRP)を用いた慢性関節炎の治療(関節内組織)Class IIJSCSF再生医療等委員会01E2509005
自家多血小板血漿(Platelet-Rich Plasma:PRP)を用いた筋肉、腱、靭帯、筋膜の損傷及び慢性炎症の治療(関節外の軟部組織)Class IIIJSCSF再生医療等委員会01E2509006
自己脂肪由来間葉系幹細胞を用いた変形性関節症治療Class II安全未来特定認定再生医療等委員会01E2511014
自己脂肪由来間葉系幹細胞を用いた靭帯・腱損傷治療Class II安全未来特定認定再生医療等委員会01E2511020

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor